TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 61 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,995,224 | +3618.9% | 265,055 | +2763.9% | 0.00% | – |
| Q4 2022 | $268,765 | -4.0% | 9,255 | -0.7% | 0.00% | – |
| Q3 2022 | $280,000 | -20.7% | 9,320 | -4.4% | 0.00% | – |
| Q2 2022 | $353,000 | -96.5% | 9,752 | -95.8% | 0.00% | -100.0% |
| Q1 2022 | $10,014,000 | -27.2% | 231,498 | -15.7% | 0.00% | 0.0% |
| Q4 2021 | $13,763,000 | -16.5% | 274,654 | +6.0% | 0.00% | -25.0% |
| Q3 2021 | $16,484,000 | +27.9% | 259,059 | +44.7% | 0.00% | +33.3% |
| Q2 2021 | $12,886,000 | +8.0% | 179,076 | +10.7% | 0.00% | 0.0% |
| Q1 2021 | $11,933,000 | +6.8% | 161,797 | +6.3% | 0.00% | 0.0% |
| Q4 2020 | $11,177,000 | +20.8% | 152,239 | -9.7% | 0.00% | 0.0% |
| Q3 2020 | $9,250,000 | -9.8% | 168,650 | +9.3% | 0.00% | -25.0% |
| Q2 2020 | $10,258,000 | +9.8% | 154,269 | +1.1% | 0.00% | 0.0% |
| Q1 2020 | $9,340,000 | -43.1% | 152,613 | -18.3% | 0.00% | -20.0% |
| Q4 2019 | $16,424,000 | +53.5% | 186,788 | +31.7% | 0.01% | +66.7% |
| Q3 2019 | $10,698,000 | -3.6% | 141,786 | +9.2% | 0.00% | 0.0% |
| Q2 2019 | $11,093,000 | -38.0% | 129,865 | -21.5% | 0.00% | -50.0% |
| Q1 2019 | $17,888,000 | +5.3% | 165,488 | -17.5% | 0.01% | -14.3% |
| Q4 2018 | $16,982,000 | -9.7% | 200,624 | +4.9% | 0.01% | +16.7% |
| Q3 2018 | $18,797,000 | -0.5% | 191,216 | +17.1% | 0.01% | 0.0% |
| Q2 2018 | $18,895,000 | +8.1% | 163,324 | -7.7% | 0.01% | -14.3% |
| Q1 2018 | $17,478,000 | -4.3% | 177,008 | +1.5% | 0.01% | 0.0% |
| Q4 2017 | $18,261,000 | +684.1% | 174,397 | +744.3% | 0.01% | +600.0% |
| Q3 2017 | $2,329,000 | +30.4% | 20,656 | +29.6% | 0.00% | 0.0% |
| Q2 2017 | $1,786,000 | +23.9% | 15,939 | +28.9% | 0.00% | – |
| Q1 2017 | $1,442,000 | +117.5% | 12,369 | +96.6% | 0.00% | – |
| Q4 2016 | $663,000 | -5.8% | 6,290 | -1.3% | 0.00% | – |
| Q3 2016 | $704,000 | -5.5% | 6,374 | +24.6% | 0.00% | – |
| Q2 2016 | $745,000 | -1.3% | 5,115 | -2.9% | 0.00% | – |
| Q1 2016 | $755,000 | +20.8% | 5,270 | +25.0% | 0.00% | – |
| Q4 2014 | $625,000 | +2.8% | 4,217 | +6.7% | 0.00% | – |
| Q3 2014 | $608,000 | +13.4% | 3,951 | +3.3% | 0.00% | – |
| Q2 2014 | $536,000 | +27.6% | 3,825 | +1.2% | 0.00% | – |
| Q1 2014 | $420,000 | – | 3,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |